Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,613 signal articles · 96 in last 24h · 155,521 total before filter · latest 2h ago
96last 24h
848last 7d
142● bullish (7d)
90● bearish (7d)
214publishers
AllMacro191Earnings105M&A124Regulatory20Product21Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Are Netflix Shares Still Worth Watching?
Zacks2d agoneutral
Are Netflix Shares Still Worth Watching?

Netflix (NFLX) has been a somewhat complicated story for some time now, with shares unable to find consistent stability. As a current Zacks Rank #4 (Sell), investors have better options available for near-term gains.

How Far Can Applied Materials Stock Move On You In A Year?
Trefis2d agoneutral
How Far Can Applied Materials Stock Move On You In A Year?

Applied Materials (AMAT) trades at about $472 today. Over roughly the coming twelve months, the options market prices a two-thirds-likely band for the stock, from a floor near $270 to a ceiling near $827. That band is the number a holder should be working with. It prices how far the stock can travel, never which way.

McDonald's Billion-Dollar Plan; Cracker Barrel Gains on Forecast | Stock Movers
Bloomberg2d agoneutralVIDEO
McDonald's Billion-Dollar Plan; Cracker Barrel Gains on Forecast | Stock Movers

On this episode of Stock Movers: - McDonald's (MCD) shares are moving on news the company's earmarking roughly $8.5 billion to help franchisees implement a multiyear plan to serve better food, improve service and make restaurants easier to run. - Cracker Barrel (CBRL) shares are gaining after the restaurant chain provided an adjusted Ebitda forecast for fiscal 2027 that beat the average analyst estimate. - KBHomes (KBH) shares are dropping after the homebuilder lowered the upper end of its housing revenue forecast for the full year. The company also cut its housing gross profit margin for 2026.

Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID
MarketBeat2d agoneutral
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID

Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with Bernstein, highlighting its mRNA platform, personalized cancer vaccine program intismeran, rare-disease pipeline and plans to expand therapeutics development. Chief Executive Office

What Makes Abbott Laboratories (ABT) an Attractive Opportunity?
Insider Monkey2d agoneutral
What Makes Abbott Laboratories (ABT) an Attractive Opportunity?

Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here. The fund highlighted a period of strong equity market gains as the S&P 500 surged ~17% following March’s selloff, driven by resilient earnings, artificial intelligence (AI) investment, and semiconductor strength. While acknowledging the strength of the AI-driven […]